LOOMIS SAYLES & CO L P - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$58,998,000
+142.1%
272,007
+28.8%
0.08%
+137.5%
Q4 2020$24,373,000
+17.8%
211,190
-0.6%
0.03%
+6.7%
Q3 2020$20,691,000
-19.2%
212,545
+1.9%
0.03%
-26.8%
Q2 2020$25,595,000
+81.0%
208,560
+29.2%
0.04%
+41.4%
Q1 2020$14,140,000161,4680.03%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders